Lumigan (bimatoprost ophthalmic solution)
Failed Impurities/Degradation Specifications.
Recalls of ophthalmic solutions and eye drops - a category hit by widely reported contamination recalls.
673 recalls in this category, newest first.
Failed Impurities/Degradation Specifications.
Failed Impurities/Degradation Specifications.
Lack of Assurance of Sterility.
Lack of Assurance of Sterility.
Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier
Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier
Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier
Failed Impurities/Degradation Specifications: stability testing results did not meet the specification for impurities.
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
Labeling: Not elsewhere classified; product labeling lacks a NDC number, net weight information and does not contain the Drug Facts Panel.
Failed Impurities/Degradation Specifications.
Lack of assurance of sterility: product was found to be empty, under-filled, or leaking.
Failed Impurities/Degradation Specifications
Chemical Contamination
Lack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.
Lack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.
Failed Impurities/ Degradation Specifications: OOS for related compound (levofloxacin n-oxide) at the 18 month stability time point.
Lack of Sterility Assurance
Subpotent Drug: concentration of product is less than labeled amount.
Lack of Assurance of Sterility; damage to the internal portion of the dropper tip portion of the container
Lack of Assurance of Sterility
Lack of Assurance of Sterility; all compounded products within expiry produced using recalled filters
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.